We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 603

Post-AstraZeneca: Has the Promise Doctrine Vanished from Patent Litigation? Likely, Yes.
  • McCarthy Tétrault LLP
  • Canada
  • October 12 2018

The Supreme Court of Canada abolished the Promise Doctrine over a year ago and, as discussed in our blog, it marked an important course correction


Can we Implement Random Cannabis Drug Testing?
  • McMillan LLP
  • Canada
  • October 12 2018

In certain circumstances an individual employee who has an alcohol or drug problem may be tested BUT random testing is not automatic. The courts may


The Costs of Medical Assistance in Dying may be Eligible for the Medical Expense Tax Credit
  • Fasken
  • Canada
  • October 1 2018

The Supreme Court of Canada in Carter v. Canada ruled that Canadians are entitled to obtain medical assistance to end their lives under appropriate


SCC denies Sobeys leave to appeal in loyalty rewards program dispute with Alberta College of Pharmacists
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • October 1 2018

On August 9, 2018, the Supreme Court of Canada denied Sobeys' application for leave to appeal (docket no. 37864) from the Alberta Court of


Helping your workplace navigate the legalization of marijuana
  • McMillan LLP
  • Canada
  • September 27 2018

The impending legalization of recreational cannabis on October 17, 2018, presents uncharted territory for employers in Canada. Individuals will soon


Tobacco companies cannot compel production of health records
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • September 26 2018

The province of British Columbia recently brought an action against Philip Morris International and other tobacco manufacturers to recover


Alexion denied leave to appeal in case challenging constitutionality of PMPRB's remedial powers
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • September 10 2018

The Supreme Court of Canada recently dismissed Alexion Pharmaceuticals' application for leave to appeal the Federal Court of Appeal decision in


Rx IP Update - July 2018
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • July 31 2018

As previously reported (here and here), the Patented Medicine Prices Review Board (PMPRB) has been consulting on its proposed reform of the federal


Supreme Court of Canada Bulletin - Appeal allowed, 13 July 2018
  • Gowling WLG
  • Canada
  • July 13 2018

The province of British Columbia brought an action against P and other tobacco manufacturers to recover the cost of health care benefits related to


CIPO's Examination Guidelines for Medical Diagnostic Methods Turn Three
  • Borden Ladner Gervais LLP
  • Canada
  • July 13 2018

This article provides a retrospective on three years of experience with the examination guidelines established by the Canadian Intellectual Property